SSY Group gains approval for two key drugs

SSY Group announced it has secured approval from China's National Medical Products Administration (NMPA) for Tranexamic Acid Tablets (0.5g) and Acipimox Capsules (0.25g). The approval for Tranexamic Acid Tablets marks the third such approval for the company's PRC entities, while the approval for Acipimox Capsules marks the fourth. Tranexamic Acid Tablets are used to treat various bleeding conditions. Acipimox Capsule is used for reducing triglyceride levels in patients who do not adequately respond to other treatments. The company stated that this announcement is intended to keep shareholders and potential investors informed of the latest business developments of the Group.